Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

MLA

van Aerts, Rene M. M., et al. “Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.” Gastroenterology, vol. 157, no. 2, Aug. 2019, p. 481. EBSCOhost, https://doi.org/10.1053/j.gastro.2019.04.018.

APA

van Aerts, R. M. M., Kievit, W., D’Agnolo, H. M. A., Blijdorp, C. J., Casteleijn, N. F., Dekker, S. E. I., de Fijter, J. W., van Gastel, M., Gevers, T. J., van de Laarschot, L. F. M., Lantinga, M. A., Losekoot, M., Meijer, E., Messchendorp, A. L., Neijenhuis, M. K., Pena, M. J., Peters, D. J. M., Salih, M., Soonawala, D., … Drenth, J. P. H. (2019). Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease. Gastroenterology, 157(2), 481. https://doi.org/10.1053/j.gastro.2019.04.018

Chicago

van Aerts, Rene M M, Wietske Kievit, Hedwig M A D’Agnolo, Charles J Blijdorp, Niek F Casteleijn, Shosha E I Dekker, Johan W de Fijter, et al. 2019. “Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.” Gastroenterology 157 (2): 481. doi:10.1053/j.gastro.2019.04.018.